Scientific Advisory Board

As part of the Centre's commitment to provide excellent, cutting-edge proteomics services, it has a scientific advisory board comprised of experts in both industry and academia. The members of this board convene on a regular basis to discuss the Centre and provide recommendations on ways to improve its services and align itself with the most recent advances in the field of proteomics.

Dr. Ron Beavis
Dr. Ron BeavisDr. Ron Beavis Dr. Beavis is a member of the Biomedical Research Centre at the University of British Columbia, where he also holds the Tier I Canada Research Chair in Experimental Bioinformatics. He obtained his Ph. D. in Physics at the University of Manitoba in Dr. Ken Standing’s Time-of-Flight lab. Dr. Beavis started his professional career as a NATO postdoctoral fellow at the Technical University of Munich. At Rockefeller University, he discovered most of the matrix compounds currently used for MALDI mass spectrometry and developed a new type of ion source that has become the basis of most commercial MALDI instrument designs. He joined Eli Lilly and Co. in 1997 and formed his own bioinformatics company Proteometrics in 1999. He sold Proteometrics to Genomic Solutions in 2003 and remained in private industry as a consultant until 2006.
Dr. Albert Heck
Dr. Albert HeckDr. Albert Heck Dr. Albert Heck is the scientific director of the Netherlands Proteomics Centre and the Bijvoet Centre for Biomolecular Research. He is also a professor in the Faculty of Science at Utrecht University in the Netherlands. His major interest is in protein mass spectrometry. The general theme of the research in his group is to develop and implement innovative mass spectrometric methods for the more efficient and detailed characterization of proteins and other biomolecules in relation to their biological function. The emphasis is on the structural characterization of proteins and post-translational modifications as well as on the investigation of protein complexes and protein interactions. Major biological current research themes entail embryonic stem cells, early embryonic development, cAMP signaling, chaperones, and viral assembly. Dr. Heck is a member of the council of the Human Proteome Organization (HUPO) and chairman of the HUPO Conference in Amsterdam in 2008. In 2001 he was recipient of the Golden Medal of the Dutch Royal Chemical Society. In 2004 he received an honoree Utrecht University “ABC”-professorship. He has currently published more than 200 papers in internationally reviewed journals. Dr. Heck is a great supporter of HUPO and serves on the Publication Committee and the Meetings Committee.
Dr. Dave Goodlett
Dr. Dave GoodlettDr. Dave Goodlett Dr. David Goodlett is an Associate Professor in the medicinal chemistry department at the University of Washington where he conducts research in bio-analytical mass spectrometry and directs the School of Pharmacy Mass Spectrometry Facility. His research includes hypothesis generating, discovery based efforts in proteomics and lipid A analysis of infectious Gram negative organisms as well cancers of the pancreas, prostate, blood and brain. Method development projects include writing new software to support these tasks, developing more efficient analytical methods for use on currently available commercial mass spectrometers and construction of a novel mass spectrometer that will increase efficiency of data extraction from samples of limited availability. Additionally, the laboratory is using mass spectrometry data together with /in silico/ protein structure prediction methods to associate structure (i.e. function) with gene products that have not been previously characterized. Prior to joining the University of Washington, Dr. Goodlett was the Director of Proteomics at the Institute for Systems Biology.
Dr. Steve Martin
Dr. Steve MartinDr. Steve Martin Dr. Steve Martin is the Global Head of Analytical Sciences for the Novartis Institute for Biomedical Research (NIBR). At Novartis he is responsible for Analytical Sciences group based in Cambridge, Massachusetts and Basel Switzerland. The group has domain expertise in a broad range of analytical methods and the appropriate technology to support the characterization of the full spectrum of compounds/projects within NIBR, from small molecules thru proteins/antibodies. The group works with disease and functional areas ensuring appropriate methods/expertise are available to move projects through the discovery pipeline. The team also has efforts in metabolomics and mass spectrometry based tissue imaging.Previously as Executive Vice President and Chief Technical Officer at BG Medicine, Dr. Martin was responsible for the development and integration of the Company’s Molecular Systems Biology platforms. Prior to joining BG, Dr. Martin was Senior Director of the Discovery Proteomics & Small Molecule Research Center (DPSM RC) at Applied Biosystems in Framingham, Massachusetts, responsible for applied research in the fields of Proteomics and Small Molecules. Prior to forming the Research Center, Dr. Martin was responsible for Research and Development in Mass Spectrometry and Chromatography..
Dr. Michael O. Glocker
Dr. Michael O. GlockerDr. Michael O. Glocker Dr. Michael O. Glocker is the director of the Proteome Center Rostock at the Medical Faculty of the University of Rostock. His current research is focused on (i) investigations of proteomes from clinical patients suffering from multigenic diseases and includes suitable model systems, and (ii) the development of advanced mass spectrometric methods in conjunction with biochemical modification reactions for the characterization of protein structures, protein folding reactions, protein degeneration processes, protein modifications, and protein-protein interactions. The Proteome Center Rostock is dedicated to the molecular characterization of diseases by making use of platform methodologies such as transcriptomics, proteomics, and bioinformatics. The bioinformatics group at the Center has developed “ProteoBase”, a fully functional LIM-system and results data base that it uses to comprehensively store proteome and transcriptome data. Dr. Glocker is a co-founder of the German Society for Proteome Research (DGPF) and is a referee for numerous scientific journals. Additionally, he is on the editorial board of the “European Journal of Mass Spectrometry”.